Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Formoterol and Revefenacin vs Albuterol and Ipratropium in Hospitalized AECOPD Patients
NCT04655170Phase 4Completed
- Sponsor
- University of Tennessee Graduate School of Medicine
- Start
- Dec 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of revefenacin, formoterol in chronic obstructive pulmonary disease (COPD), sponsored by University of Tennessee Graduate School of Medicine. Started Dec 2020; status: completed.
02
Drugs
revefenacinformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04655170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04655170.